FDA Approves Igalmi for Agitation Associated With Schizophrenia, Schizoaffective Disorder, or Bipolar I or II Disorder
🤖 Summarise this story with AI:
This headline comes from Google News’s public news feed. The full article, images and copyright belong to the publisher.